Patrick Campbell

A Family Heart Database analysis found lipoprotein(a) [Lp(a)] testing prevalence was just 1.1% among US adults, while a companion at-home screening

A trio of analyses from LIBERTY AD PEDS, LIBERTY AD PRESCHOOL, and the long-term PED-OLE extension study show dupilumab (Dupixent) improves growth

Endogenous hypercortisolism was nearly twice as common in individuals with resistant hypertension and an estimated glomerular filtration rate (eGFR) below

Recapping 5 practice-changing FDA decisions from the first half of 2026, including icotrokinra, expanded pediatric indications, and more!

Fact checked by: Ryan Livingston Key Takeaways FCS typically reflects biallelic LPL loss-of-function, with chylomicron/VLDL

Northwestern researchers identify a reduced CSF protein signal in schizophrenia and show a synthetic version restores brain circuit activity in mice.

A first-in-vivo PET study finds M1 receptor availability reduced 13% to 19% across brain regions in schizophrenia, strengthening the case for muscarinic-targeted treatment.

Published on: Ziltivekimab did not reduce the risk of major adverse cardiovascular events (MACE) versus placebo in people with atherosclerotic

Retrospective cohort study of 1305 adults finds specialized virtual behavioral health care produced clinically meaningful gambling symptom improvement within 14 days.

Published on: The US Food and Drug Administration (FDA) has granted accelerated approval to pariglasgene brecaparvovec-opnr (Genglycos), a